News

After-Hours Surge: McGraw Hill (MH) Sees Stock Spike Ahead

After-Hours Surge: McGraw Hill (MH) Sees Stock Spike Ahead

McGraw Hill Inc. Stock Price Rise Following Earnings Report

In a surprising turn of events, McGraw Hill Inc. saw its shares soar by 18.72%, reaching $14.65 during after-hours trading. This remarkable surge followed the company's announcement of its fiscal third-quarter results, which have managed to impress investors across the board.

Strong Q3 Performance Drives Momentum

Growth in Revenue and Adjusted Earnings

The financial report disclosed that McGraw Hill generated a revenue of $434.2 million for the quarter ending December 31, showcasing a 4.2% increase from the previous year's same quarter. A significant contributor to this growth was the Higher Education revenue, which surged by an impressive 24% to $225.4 million. However, it's worth mentioning that K-12 revenue experienced a decline of 14.6%, totaling $128.2 million.

Improved Financial Metrics

McGraw Hill's adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) also saw a substantial increase—reaching $135.9 million with a margin of 31.3%, showing an upward movement of approximately 100 basis points. The company reported a narrowed net loss under generally accepted accounting principles (GAAP), which improved to $20.2 million, compared to a larger loss of $52.9 million from the prior-year period.

Leadership Changes and Future Outlook

New President and CEO Announcement

As part of its operational reshuffle, McGraw Hill appointed Philip Moyer as its new president and CEO, effective February 9. He replaces Simon Allen, who has transitioned to the role of board chair. Moyer's leadership is expected to steer the company towards a prosperous future, leveraging its strong market position.

Increased Debt Paydown

In a bid for financial stability, McGraw Hill has accelerated its debt paydown strategy, making $200 million in term loan prepayments during the quarter. This proactive approach underscores the company's commitment to improving its financial health.

Guidance Updated on Digital Advancements

Positive Revision in Revenue Guidance

McGraw Hill has also raised its fiscal 2026 revenue guidance, now projecting figures between $2.067 billion and $2.087 billion, an increase from the previous range of $2.031 billion to $2.061 billion. Similarly, adjusted EBITDA guidance is now set between $729 million and $739 million, compared to the earlier estimate of $702 million to $722 million.

Technical Analysis and Market Position

Current Trading Metrics

The Relative Strength Index (RSI) for MH currently stands at 31.91. The company's market capitalization is recorded at $2.36 billion, with a 52-week high of $18 and a low of $10.70.

Stock Performance Overview

Over the past year, MH's stock price has declined by 27.41%. Nevertheless, the current trading position reflects the stock is approximately 22.5% above its 52-week low, indicating that it is on the lower end of its annual range. Those interested in investing should remain cautious, as the stock's long-term trend and unstable position suggest that any potential recovery may require credible confirmation.

Price Action and Market Sentiment

Closing Figures

As of Wednesday’s close, McGraw Hill's stock was down 5.08%, sitting at $12.34. The recent surge in after-hours trading, however, has caught many investors' attention, providing a glimpse into possible recovery.

Market Sentiment Analysis

Despite the recent positive movement in stock price, broader analyses suggest that MH exhibits a negative price trend across various time frames. Investors are advised to remain vigilant and monitor the developments closely as the updated guidance and strategic moves unfold.

Frequently Asked Questions

What caused the recent stock surge for McGraw Hill?

The surge was primarily due to the company’s impressive fiscal third-quarter results and improved forward guidance.

How much did McGraw Hill's stock rise after-hours?

The stock rose by 18.72% in after-hours trading, reaching $14.65 following the earnings report.

What is the company’s updated revenue guidance?

The company raised its fiscal 2026 revenue guidance to between $2.067 billion and $2.087 billion.

Who is the new CEO of McGraw Hill?

Philip Moyer has been appointed as the new president and CEO, taking over from Simon Allen.

How does McGraw Hill's stock perform in the market?

McGraw Hill is currently trading approximately 22.5% above its 52-week low, but it still faces a negative price trend overall.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 12

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Secures $300 Million Loan for Growth

Updated Category News Views 255

America's Car-Mart Secures Funding for Future Growth America's Car-Mart, Inc. (NASDAQ: CRMT), a leading automotive retailer, has taken a strategic step by closing a significant five-year, $300 million term loan. This loan, managed by the seasoned professionals at Silver Point Capital, L.P., aims to enhance the company’s capital structure and support its long-term growth...

Continue Reading
IASO Bio's Breakthrough Drug Application Acceptance in Singapore

Updated Category News Views 251

IASO Bio’s Major Step Forward with New Drug Application IASO Biotherapeutics, a pioneering biopharmaceutical company dedicated to the advancement of innovative cell therapies and biologics, has reached a significant milestone. The Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel, known as...

Continue Reading
Creating Community Leaders: National Heritage Academies and United Way

Updated Category News Views 150

Empowering Students to Make a Difference The student-led organization is providing career opportunities while connecting with the community. National Heritage Academies® (NHA) is thrilled to celebrate its collaboration with United Way through the Student United Way program. This initiative equips high school students with essential tools and opportunities to enact...

Continue Reading
Future Growth of Augmented and Virtual Reality Technologies

Updated Category News Views 259

Exploring the Growth of Augmented Reality and Virtual Reality Market The global market for Augmented Reality (AR) and Virtual Reality (VR) is on the rise, with expectations of substantial growth over the next few years. Analysts estimate that this sector will expand by approximately USD 442.99 billion between 2024 and 2028. The compound annual growth rate (CAGR) for this...

Continue Reading
ImmVira Launches Innovative Exosome, Transforming Cosmetics

Updated Category News Views 407

ImmVira Leads the Way with Groundbreaking Exosome Technology In a remarkable advancement for the cosmetic industry, ImmVira Group has announced its innovative product, MVR-EX103, an engineered exosome specifically developed for treating superficial skin depressions. This development marks a pivotal moment, as it has successfully acquired the International Nomenclature...

Continue Reading